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Results: The resorption pits made by osteoclasts were well
demonstrated on the cortical bone plates. The area of the re-
sorption pits became larger sequentially on day 3, 5, and 7
in osteoclast-cell culture. In the STZ group, the resorption-pit
area was signiﬁcantly decreased compared with that in control
group. The expression levels of MMP9, Catepsin-K, and RANK
showed no difference in between control and STZ group. On the
other hand, expression levels of DC-STAMP were signiﬁcantly
decreased in STZ group.
Conclusions: In the last meeting, we reported that the osteoclast
fusion was impaired, the cartilage resorption was decreased,
and the endocondral ossiﬁcation was delayed in the STZ-induced
diabetic mice. In this study, we found that the impaired bone
resorption in STZ might be produced by a decreased expression
of DC-STAMP in osteoclasts. Since DC-STAMP has a central role
for the formation of multinuclear osteoclasts, our result indicates
that the up-regulation of DC-STAMP may be useful to prevent
osteopenia in diabetes mellitus.
159
COMPRESSION INDUCES THE EXPRESSION OF A
SCLEROTIC PHENOTYPE IN HUMAN SUBCHONDRAL
OSTEOBLASTS
C. Sanchez1, O. Gabay2, L. Pesesse1, P. Msika3, C. Baudouin3,
Y.E. Henrotin1
1Univ. of Liège, Liège, Belgium; 2NIH, Bethesda, MD;
3Laboratoires ExpanSci., Epernon, France
Purpose: Recent data showed that subchondral bone plays an
important role in osteoarthritis (OA). Metabolic and morphologic
modiﬁcations in this tissue contribute to the degradation of the
overlaying cartilage. It was suggested that abnormal mechani-
cal pressure applied to the articulation was responsible to these
changes. Here, we evaluated the effects of compression on os-
teoblasts from subchondral bone.
Methods: Osteoblasts were isolated from sclerotic (SC) or non-
sclerotic (NSC) areas of human OA subchondral bone. After 28
days, osteoblasts were surrounded by a newly synthesized ma-
trix and formed a strong membrane. This osteoblasts-containing
membrane was then placed onto a Biopress Flexercell plate and
submitted to compression (1.67 MPa) for 4 hours at the frequency
of 1 Hz. The expression of IL-6, IL-8, COX-2, VEGF, IGF-1, OPG
and RANKL was evaluated by RT-PCR. IL-6, IL-8 and PGE2 were
quantiﬁed by ELISA.
Results: Basal IL-6, VEGF, COX-2, IGF-1 and RANKL mRNA
levels were signiﬁcantly increased in SC osteoblasts as compared
to NSC. By contrast, SC osteoblasts expressed less OPG than
those from NSC areas. Compressions induced the expression of
genes coding for IL-6, IL-8, COX-2, IGF-1, VEGF and RANKL but
decreased the expression of OPG in NSC osteoblasts (p<0.01).
IL-6, IL-8 and PGE2 productions were also stimulated by com-
pressions. Interestingly, compressed NSC osteoblasts expressed
similar levels of these genes than SC osteoblasts, suggesting that
mechanical strains could be responsible for SC phenotype.
Conclusions: These results indicate that in response to com-
pression NSC osteoblasts expressed a phenotype similar to that
of SC osteoblasts. Moreover, SC osteoblasts are less sensitive
to mechanical stimuli than NSC osteoblasts. These results clarify
the role of compression in the pathogenesis of subchondral bone
sclerosis and allow new perspectives of research in this ﬁeld.
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INVOLVEMENT OF CCL20 CHEMOKINE IN BONE TISSUE
REMODELING: EVIDENCE IN SUBCHONDRAL BONE OF
OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS
PATIENTS
G. Lisignoli, C. Manferdini, A. Piacentini, E. Gabusi, F. Grassi,
L. Cattini, A. Facchini
Istituti Ortopedici Rizzoli, Bologna, Italy
Purpose: Bone tissues are remodeled through cycling of bone re-
sorption and new bone formation that are dependent by the activity
of osteoblasts and osteoclasts. Subchondral bone remodelling in
osteoarthritis (OA) and rheumatoid arthritis (RA) is mainly charac-
terized by the formation of osteophytes/ﬁbrosis and by the pres-
ence of inﬁltrating cells associated to bone resorption. In this study
we analysed on subchondral bone of OA and RA patients both
the expression of CCL20 chemokine and its receptor CCR6 on
osteoblasts, osteoclasts, osteocytes and inﬁltrating mononuclear
cells. Then we analysed its effects on osteoblasts and osteoclasts.
Methods: CCL20 and CCR6 expression was evaluated in sub-
chondral bone tissue biopsies by immunohistochemical techniques
and the percentage of positive cells was manually counted. Func-
tional assays (cell proliferation, matrix proteins expression, apop-
totic markers, signalling factor and osteoclast differentiation) on
osteoblasts and osteoclasts were performed to assess the func-
tional role of CCL20.
Results: CCL20 was positive on osteoblasts (60%) and osteo-
cytes (20%) from RA patients, while it was expressed only in
OA osteoblasts located in area of new bone formation. Both in
OA and RA biopsies, osteoclasts were highly positive to CCL20
while mononuclear cells were 10% positive in OA and 60% in
RA. The percentage of osteoblasts positive to CCR6 was not
different in OA versus RA biopsies, while the percentage of os-
teocytes and mononuclear cells positive to CCR6 was signiﬁcantly
higher in RA compared to OA. CCL20 did not affected both
the expression of different matrix proteins (i.e. bone sialopro-
tein, collagen type I, osteopontin and osteocalcin) and apoptotic
markers (like caspases 3 and 8) in OA and RA osteoblasts.
CCL20-stimulated OA osteoblasts showed a signiﬁcant increase
in β-N-acetylhexosaminidase release compared to RA while os-
teoblasts proliferation was higher only in CCL20-stimulated RA
osteoblasts associated to Akt phosphorylation. IL1β and TNFα
differently modulated CCL20, RANKL/OPG expression in OA and
RA osteoblasts. Moreover, we found that CCL20 was an early
inducer (at day3) of cell fusion events, osteoclasts differentiation
and MMP-9 release.
Conclusions: This study demonstrates a different expression of
CCL20 positive osteoblasts in OA versus RA disease that seems
to be associated with the presence of inﬁltrating mononuclear
cells. Moreover, the contemporary action of CCL20 on osteoblasts
and osteoclasts that resulted in a greater proliferative response
in RA osteoblasts compared to OA and an increased enzymatic
activity in OA osteoblasts, clearly suggests a differential role of
this chemokine in OA and RA.
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NUCLEAR RECEPTOR RETINOID-RELATED ORPHAN
RECEPTOR ALPHA1 MODULATES OSTEOBLAST
METABOLISM WITH ANTI-INFLAMMATORY EFFECTS
M. Benderdour, J.C. Fernandes, P. Lavigne, F. Beaudet, Q. Shi
Univ. of Montreal, Montreal, QC, Canada
Purpose: To elucidate the expression and function of nuclear
receptor retinoid-related orphan receptor alpha1 (RORalpha1) in
human MG-63 osteoblast-like cells.
S96 Poster Presentations
Methods: Expression of RORalpha isoforms was analyzed by
semi-quantitative reverse transcriptase chain reaction (RT-PCR)
and immunocytochemistry. RORalpha1 overexpression and down-
expression were achieved by the transfections of expression vec-
tor and small interfering RNA (siRNA) of RORalpha1, respectively.
Their effects on the modulation of osteoblast metabolism markers
and tumor necrosis factor alpha (TNFalpha) induced inﬂamma-
tory response markers were determined by real-time RT-PCR,
western blot, enzyme-linked immunosorbent assay, gene reporter
luciferase assay and electrophoretic mobility shift assay.
Results: The overexpression of RORalpha1 increased alkaline
phosphatase (ALP), osteocalcin (OC) and collagen type I (COL
I) mRNA and activity or protein expression, while the silenc-
ing of RORalpha1 RNA inhibited these responses. In addition,
overexpression of RORalpha1 suppressed TNFα-induced produc-
tion of cyclooxygenase-2 (COX-2), prostaglandins E2 (PGE2) and
metalloproteinase-9 (MMP-9). Upon examination of signaling path-
ways, we found that RORalpha1 was able to block TNF alpha-
induced nuclear factor kappa B (NF-kB) activation.
Conclusions: RORalpha1 is involved in human osteoblast
metabolism by stimulating osteoblast marker expression and in-
hibiting inﬂammatory responses. These ﬁndings may encourage
further exploration of RORalpha1 as a potential target for the
treatment of bone disorders related to inﬂammation.
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A LOWER OSTEOPROTEGERIN/RANKL RATIO IS
ASSOCIATED WITH AN INCREASED SUBCHONDRAL BONE
REMODELING IN OSTEOARTHRITIS AGGRAVATED BY
PRIOR OSTEOPOROSIS IN RABBITS
M. Bellido1, L. Lugo1, S. Castañeda2, R. Largo1,
G. Herrero-Beaumont1
1Fundacion Jimenez Diaz, Madrid, Spain; 2Hosp. de la Princesa,
Madrid, Spain
Purpose: In previous studies, we have observed that prior sub-
chondral bone (SB) osteoporosis (OP) aggravated the cartilage
damage in a combined model of OP and osteoarthritis (OA) in
rabbits (Calvo et al. Osteoarthritis Cartilage 15:69-77, 2007). In
this work, our aim was to study whether an increased SB remod-
eling could account for the increased cartilage damage in rabbits
with OA aggravated by prior subchondral OP.
Methods: OP was induced in 20 (8 month-old; 3.5-4.8 kg body
weight), skeletally mature female NZ rabbits, by ovariectomy (OVX)
and intramuscular injections of methylprednisolone hemisuccinate
(1 mg/kg/day for 4 weeks; OP group). Ten age and gender-
matched additional animals were used as controls. Surgical OA
was simultaneously induced in the left knees of all the rabbits
through partial medial meniscectomy and anterior cruciate liga-
ment transection. The animals were sacriﬁced 22 weeks after
OVX. Then, left knees were considered as OA or as OA plus
OP (OPOA) and the right knees were used as OP or healthy
controls, respectively. The percentage of bone area/tissue area
(BAr/TAr) was assessed in the SB of the femurs after sacri-
ﬁce by micro- Computed Tomography. Osteoprotegerin (OPG),
RANKL and MMP-9 protein synthesis at the SB were evaluated
by western-blot studies. Nonpair-wise statistical comparisons were
done using Mann-Whitney test for the different variables studied
and correlations by Spearman’s test (SPSS vs. 15).
Results: At sacriﬁce, the BAr/TAr in the SB was signiﬁcantly di-
minished in OP, OA and OPOA knees when compared to healthy
knees (p<0.05), although a greater decrease was observed in the
OPOA knees (p<0.05 vs. OP and vs. OA). At SB, the OPG/RANKL
protein synthesis ratio was signiﬁcantly diminished in OA, OP
and OPOA knees when compared to healthy controls (Healthy:
1.36±0.14; OA: 1±0.02*; OP: 0.91±0.1*; OPOA: 0.7±0.04* ar-
bitrary units; *p<0.05 vs. healthy), although it was signiﬁcantly
lower in OPOA knees when compared to OP or to OA (p<0.05 for
both comparisons). MMP-9 protein synthesis in the SB was signif-
icantly increased both in OA and in OPOA knees in comparison
to healthy knees (Healthy: 100±7; OA: 362±90*; OP: 284±80;
OPOA: 690±180* arbitrary units; *p<0.05 vs. healthy). Further-
more, a signiﬁcantly greater increase was observed for OPOA
knees in comparison to OA knees. In addition, we observed a
positive correlation between BAr/TAr and OPG/RANKL ratio in the
SB of these rabbits (r=0.911; p=0.001).
Conclusions: The remodeling parameters BAr/TAr, OPG/RANKL,
both analyzed in the SB, were diminished in OA, OP and even
more in OPOA. In the same way, the MMP-9 synthesis was greater
in OPOA than in OA rabbits. Our results show that an increased
SB remodeling can be responsible for the severity of cartilage
damage in OA, at least in rabbits with prior OP. This ﬁnding can be
relevant since these pathologies are frequently found in the same
patients, in which OP can precede OA onset.
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OSTEOCLAST PHENOTYPE AND RESORPTIVE ACTIVITY
ARE MODIFIED DISTINCTLY BY DIFFERENT TYPES OF
OSTEOCLAST INHIBITORS - IMPLICATIONS FOR
OSTEOCLAST QUALITY?
A.V. Neutzsky-Wulff, M.G. Soerensen, D. Kocijancic,
A.-C. Bay-Jensen, M.A. Karsdal, K. Henriksen
Nordic BioSci. A/S, Herlev, Denmark
Purpose: Osteoarthritis (OA) is described as being a disorder that
has its origin in bone and cartilage. It is therefore interesting to
investigate the biological action of bone resorping cells also known
as the osteoclasts. Osteoclast inhibition can be used to investigate
the biological processes underlying bone remodeling; however the
direct effect on osteoclast phenotype caused by modulation of
both the organic and inorganic phase of bone during resorption
has not been investigated in detail. The aim of the current study
was to investigate the phenotype of resorptive human osteoclasts
after treatment with different types of inhibitors and thereby gain
more knowledge about bone turnover.
Methods: Mature human osteoclasts, generated from CD14+
monocytes, were seeded on bone slices and treated with inhibitors
of acidiﬁcation (baﬁlomycin; diphyllin; ethoxyzolamide), inhibitors
of proteolysis (E64 [cat. K inhibitor]; GM6001 [MMP inhibitor]) or a
bisphosphonate (Ibandronate). Bone resorption was measured by
Ca2+ (inorganic), CTX-I (organic), ICTP (organic, MMP generated)
and pit scoring. In addition, gelatinase activity and the osteoclast
marker TRACP were measured.
Results: All inhibitors of acidiﬁcation were equally potent with
respect to inhibition of organic and inorganic resorption, measured
both by resorption markers and pit scoring. Conversely, E64 ef-
fectively reduced organic resorption by 80%, whereas inorganic
resorption was modestly reduced. Resorbed bone area, ICTP
release and gelatinase activity were all increased for this treat-
ment. Treatment with GM6001 had no effect on neither organic
nor inorganic resorption alone; however, when combined with E64
degradation of the organic phase of bone was abrogated, whereas
inorganic resorption was reduced by 60%. Ibandronate completely
abrogated both organic and inorganic resorption, while TRACP
activity was strongly decreased.
Conclusions: Inhibitors of acidiﬁcation and Ibandronate potently
reduced both organic and inorganic resorption to the same level.
In face of that, inhibition of proteolysis leads to potent reduction
of organic resorption, but only modest reduction of inorganic
resorption, and even an increased resorbed bone area, possibly
due to MMP mediated compensation. These ﬁndings strongly
indicate that different anti-osteoclastic intervention strategies affect
